U.S. Office REITs Stock News

Agios Pharmaceuticals (AGIO) stock is back in focus after the company shared detailed 52 week data from its RISE UP Phase 3 trial of mitapivat in sickle cell disease at EHA 2026. See our latest analysis for Agios Pharmaceuticals. Agios Pharmaceuticals shares have recently picked up momentum, with a 7 day share price return of 10.25% and a 30 day share price return of 12.87%. However, the 1 year total shareholder return is still down 10.31%, showing short term enthusiasm against a mixed longer...

Recent commentary around Halozyme Therapeutics (HALO) has centered on its collaborations with large pharmaceutical partners and its use of recombinant human hyaluronidase technology to broaden injectable biologic delivery and expand global reach. See our latest analysis for Halozyme Therapeutics. Recent updates around Medicare drug price negotiations and technical trading signals have coincided with Halozyme Therapeutics’ 10.07% 90 day share price return and a 31.03% 1 year total shareholder...

LPL Financial Holdings (LPLA) has drawn fresh attention after reporting May 2026 metrics that showed 3.1% growth in total client assets, with advisory assets reaching 60.2% of the total, alongside $8.8 billion in organic net new assets. See our latest analysis for LPL Financial Holdings. The recent May asset update and the addition of new advisory teams have come alongside a 6.29% 90 day share price return, even as the year to date share price return is down 16.13% and the 1 year total...

If you are wondering whether Eli Lilly stock still offers reasonable value after its huge run, this article will walk through what the current price might be implying. The stock trades around US$1,122.50, with returns of 11.7% over the past month, 3.9% year to date, 42.9% over the past year, very large gains over three years and around 7x over five years. This naturally raises questions about growth expectations and risk. Recent headlines around Eli Lilly have centered on its position in...

On 10 June 2026, GitLab expanded its collaboration with Google Cloud to offer a managed, sovereign DevSecOps platform and unveiled new AI-powered features like Next Generation Source Code Management, GitLab Orbit, and enhanced agent governance to support large-scale, compliant software delivery. A distinctive angle is GitLab’s push to combine fast, token-efficient AI agents with fine-grained security and compliance controls, directly targeting heavily regulated enterprises that need both...

Macerich (MAC) stock has drawn investor attention after its recent performance, with the share price closing at $23.75 and total return figures highlighting a mix of shorter and longer term outcomes. See our latest analysis for Macerich. Recent trading has been choppy for Macerich, with the share price falling 5.34% over the last day even after a 30 day share price return of 9.95% and a year to date share price return of 28.24%. The 1 year total shareholder return of 55.45% and 3 year total...

Dynatrace (DT) is back in focus after multiple major banks, including UBS, initiated or upgraded coverage with positive commentary on its AI observability platform and potential for improved revenue performance. See our latest analysis for Dynatrace. The recent upgrades have come alongside a 30 day share price return of 8.08% and a 90 day share price return of 3.03%, even as the 1 year total shareholder return is down 25.83%. This indicates near term momentum against a weaker longer term...

Benchmark's Benjamin Klieve recently reiterated a positive view on Andersons (ANDE) and raised earnings estimates after management outlined a supportive macro backdrop and growth opportunities during a non-deal roadshow with investors. See our latest analysis for Andersons. At a share price of $69.21, Andersons has given investors a year to date share price return of 30.46%, while its 1 year total shareholder return of 89.30% and 5 year total shareholder return of 150.23% point to momentum...

Deere recently reported a strong first-quarter performance, with revenues surpassing analysts’ expectations and especially strong results in its Small Agriculture and Construction & Forestry divisions. At the same time, a US$99 million settlement over repair restrictions and investor commentary on an improving downcycle backdrop underscored how Deere’s diversified model and evolving customer relationships are shaping its longer-term business profile. We’ll now explore how Deere’s...

Earlier this month, CRISPR Therapeutics AG filed a shelf registration for up to US$969.16 million in common shares tied to an ESOP-related offering, while shareholders approved amendments to the company’s articles of association at the June 4, 2026 annual meeting. Against a backdrop of earnings estimate revisions, revenue growth expectations, and a valuation premium versus peers, these capital and governance moves come as investors reassess CRISPR Therapeutics’ long‑term profile and...

Red Rock Resorts (RRR) stock drew attention after recent trading data showed a move of about 18% over the past month, prompting investors to reassess the Las Vegas-focused casino operator’s current valuation. See our latest analysis for Red Rock Resorts. That recent 18.4% 30 day share price return sits against a more mixed picture, with the share price roughly flat year to date while the 1 year total shareholder return of 24.6% points to momentum that has played out over a longer horizon. If...

MBX Biosciences (MBX) has drawn fresh attention after publishing full Phase 2 Avail and one-year open-label data for its lead candidate canvuparatide in chronic hypoparathyroidism, alongside confirming plans for a pivotal Phase 3 trial. See our latest analysis for MBX Biosciences. Against this backdrop, MBX Biosciences stock has seen strong momentum, with a 7 day share price return of 29.36% and a 90 day share price return of 41.01%, while the 1 year total shareholder return is very large at...

L3Harris Technologies (LHX) stock is under the spotlight after the company was selected by the U.S. Army for a VAMPIRE counter Unmanned Systems contract worth up to US$106 million. See our latest analysis for L3Harris Technologies. At a share price of US$310.45, L3Harris Technologies has seen a 1-year total shareholder return of 25.76% and a 3-year total shareholder return of 68.66%. Over the same period, the 90-day share price return declined 15.73%, suggesting recent weakness contrasts with...

Why Douglas Dynamics Stock Is Back on Investors' Radar Douglas Dynamics (PLOW) has drawn fresh attention after being added to the Zacks Rank #1 list, following a 15.4% increase in earnings estimates and recent strong quarterly results. See our latest analysis for Douglas Dynamics. At a share price of $47.26, Douglas Dynamics has seen momentum build, with a 30-day share price return of 6.83%, a 90-day share price return of 15.66%, and a 1-year total shareholder return of 69.38%, supported by...

In the past week, EZCORP drew higher trading interest as investors reacted to expectations for upcoming quarterly earnings of US$0.39 per share and projected revenue of US$405 million, both seen higher than the prior year. This shift in sentiment highlights how earnings and revenue forecasts can quickly reshape perceptions of EZCORP’s operating momentum and business trajectory. We’ll now examine how these stronger earnings and revenue expectations could influence EZCORP’s investment...

SiTime (SITM) is back in focus after fresh news on its timing systems for AI and data center uses, combined with expanded enterprise AI deployments and a debate over potential overvaluation. See our latest analysis for SiTime. SiTime's recent AI and data center headlines arrive after a sharp 99.21% 90 day share price return and a 210.40% 1 year total shareholder return. At the same time, the 30 day share price return declined 11.52%, which hints that momentum has cooled in the very short term...

Avis Budget Group recently confronted its strained finances by issuing US$650.00 million of asset-backed securities to fund and refinance its U.S. vehicle fleet, against a backdrop of high leverage, cumulative losses, and a Ba3 credit rating with a negative outlook from Moody’s. The combination of sustained losses, negative shareholders’ equity, and reliance on secured funding highlights a business model under pressure from refinancing risk and margin erosion. We’ll now examine how Avis...

McKesson (MCK) stock is in focus after a cluster of recent moves, including a US$2.25b senior secured term loan maturing in 2032, a minority sale in Medical-Surgical Solutions and ongoing share repurchases. See our latest analysis for McKesson. After a weaker quarter and a pullback that left the 90 day share price return down 14.66% and the year to date share price return down 4.62%, McKesson still has a 1 year total shareholder return of 8.87% and a very large 5 year total shareholder...

Tariff refunds and trade litigation are reshaping the risk and cash flow profile for import heavy US industrials and retailers, and that matters if you own or are watching these stocks. With billions of dollars in potential refunds moving through the system and fresh uncertainty from the US government’s appeal, some companies could see meaningful liquidity support while others face delays and legal hurdles. This article highlights 3 stocks exposed to this tariff refund story from our Import...

Champion Homes (SKY) drew increased attention after its first quarter report, where revenue and adjusted operating income came in ahead of analyst estimates, and the stock has since moved higher on the news. See our latest analysis for Champion Homes. The first quarter beat appears to have shifted sentiment toward Champion Homes, with the stock delivering a 21.79% 1 month share price return and a 33.80% 1 year total shareholder return, even though the year to date share price return remains...

The Federal Reserve’s latest meeting is putting interest rates, the US Dollar, and inflation expectations back at the center of portfolio decisions. With markets watching for hawkish hints from Chair Kevin Warsh and the Summary of Economic Projections, currency moves could have a meaningful impact on companies that earn a large share of their revenue in US Dollars. This article highlights three stocks from the US Dollar Beneficiaries screener that appear well placed to be positively exposed...

In mid-June 2026, Jefferies Financial Group Inc. announced several new callable senior unsecured fixed-rate notes maturing between 2031 and 2051, while also completing smaller fixed-income offerings earlier that month at par with modest discounts. At the same time, Jefferies raised its copper price forecasts following an interim US-Iran peace agreement that eased geopolitical tensions and supported expectations for steadier metals demand. We’ll now examine how Jefferies’ higher copper...

JPMorgan Chase (NYSE:JPM) has joined a Quantum-AI research partnership in London with OQC and AMD to build a dedicated enterprise platform for financial algorithms and workflows. The bank will be the first enterprise user of this Quantum-AI platform, targeting new use cases in financial services technology. Separately, JPMorgan Chase has been named among the companies required to preserve records in an investigation linked to Jeffrey Epstein’s Zorro Ranch. These developments relate to both...

In recent days, BTIG named Rithm Capital as its top pick in the U.S. mortgage sector for the second half of 2026, highlighting resilient mortgage demand and an improving operating backdrop despite a more challenging interest-rate setting. At the same time, analyst expectations for flat earnings per share alongside a projected double-digit increase in quarterly revenue suggest that efficiency gains and business mix, rather than headline profit growth alone, are becoming central to how...